Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Ultrapar
UGP
$6.95B
| $1.91M | ﹤0.01% |
582,781
-6,840
| -1% | -$20.7K |
|
1502
Enliven Therapeutics
ELVN
$4.08B
| $1.89M | ﹤0.01% |
94,012
+9,312
| +11% | +$176K |
|
1503
Xeris Biopharma Holdings
XERS
$1.39B
| $1.86M | ﹤0.01% |
399,291
+7,192
| +2% | +$33K |
|
1504
Amylyx Pharmaceuticals
AMLX
$2.21B
| $1.85M | ﹤0.01% |
288,618
-2,064
| -0.7% | -$10K |
|
1505
Theravance Biopharma
TBPH
$874M
| $1.85M | ﹤0.01% |
167,429
+12,000
| +8% | +$117K |
|
1506
Williams-Sonoma
WSM
$27.6B
| $1.84M | ﹤0.01% |
11,268
+2,391
| +27% | +$375K |
|
1507
Chunghwa Telecom
CHT
$32.8B
| $1.84M | ﹤0.01% |
+39,488
| New | +$1.68M |
|
1508
CAE Inc. Common Shares
CAE
$8.47B
| $1.83M | ﹤0.01% |
62,655
+175
| +0.3% | +$4.41K |
|
1509
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
| $1.83M | ﹤0.01% |
11,112
| – | – |
|
1510
First Internet Bancorp
INBK
$256M
| $1.83M | ﹤0.01% |
67,844
| – | – |
|
1511
Aecom
ACM
$9.54B
| $1.82M | ﹤0.01% |
16,099
+43
| +0.3% | +$4.46K |
|
1512
Broadridge
BR
$18.2B
| $1.81M | ﹤0.01% |
7,461
+1,612
| +28% | +$383K |
|
1513
Anavex Life Sciences
AVXL
$266M
| $1.8M | ﹤0.01% |
194,921
+7,921
| +4% | +$67.6K |
|
|
ANSS
1514
DELISTED
Ansys
ANSS
| $1.79M | ﹤0.01% |
5,092
+418
| +9% | +$137K |
|
1515
AnaptysBio
ANAB
$1.58B
| $1.78M | ﹤0.01% |
80,213
+4,192
| +6% | +$87.7K |
|
1516
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $1.75M | ﹤0.01% |
33,505
-5,062
| -13% | -$251K |
|
1517
Simulations Plus
SLP
$371M
| $1.71M | ﹤0.01% |
98,176
-2,079
| -2% | -$58.3K |
|
1518
Trimble
TRMB
$13.4B
| $1.71M | ﹤0.01% |
22,452
+1,073
| +5% | +$72.1K |
|
|
DFTX
1519
Definium Therapeutics
DFTX
$5.63B
| $1.7M | ﹤0.01% |
261,953
+36,025
| +16% | +$237K |
|
1520
Abercrombie & Fitch
ANF
$4.68B
| $1.69M | ﹤0.01% |
20,412
-387,342
| -95% | -$29.4M |
|
1521
International Bancshares
IBOC
$4.73B
| $1.69M | ﹤0.01% |
25,391
+3
| +0% | +$187 |
|
1522
Phibro Animal Health
PAHC
$1.49B
| $1.69M | ﹤0.01% |
66,085
+2,972
| +5% | +$64.8K |
|
1523
First Community Corp
FCCO
$327M
| $1.68M | ﹤0.01% |
68,738
| – | – |
|
1524
Zoom
ZM
$29B
| $1.67M | ﹤0.01% |
21,380
-9,641
| -31% | -$745K |
|
1525
Thomson Reuters
TRI
$44.4B
| $1.66M | ﹤0.01% |
8,158
-39
| -0.5% | -$7.43K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.